SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Ansell Limited ANSLY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • AU • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Ansell Limited (ANSLY) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $83.53. It has a SharesGrow Score of 60/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Financials: revenue is $2.0B, +3.7%/yr average growth. Net income is $102M, growing at -7.4%/yr. Net profit margin is 5.1% (thin). Gross margin is 41.2% (+7.4 pp trend).

Balance sheet: total debt is $806M against $2.0B equity (Debt-to-Equity (D/E) ratio 0.41, conservative). Current ratio is 2.13 (strong liquidity). Debt-to-assets is 24.2%. Total assets: $3.3B.

SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 30/100 (Fail), Past 100/100 (Pass), Health 67/100 (Partial), Moat 67/100 (Partial), Future ?/100 (Fail), Income 45/100 (Partial).

ANSLY SharesGrow Score Overview

62/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 60/100

Valuation — P/E, PEG, Forward PEG

GROWTH 30/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 67/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 45/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ANSLY

ANSLY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

ANSLY: +3.7%/yr revenue is, -7.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

ANSLY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet ANSLY: Debt-to-Equity (D/E) ratio 0.41 (conservative), Current ratio is 2.13 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

ANSLY: Gross margin is 41.2% (+7.4 pp trend), $3B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 67/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

ANSLY: Net profit margin is 5.1%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range71.79-96.27

Volume139

Avg Volume (30D)21

Market Cap$3.01B

Beta (1Y)0.61

Dividend Yield$2.1188

Share Statistics

EPS (TTM)2.80

Shares Outstanding$36.33M

IPO Date2013-02-27

Employees15,000

CEONathalie Ahlstrom

Financial Highlights & Ratios

Revenue (TTM)$2B

Gross Profit$825M

EBITDA$260.2M

Net Income$101.6M

Operating Income$109.1M

Total Cash$238.3M

Total Debt$805.6M

Net Debt$567.3M

Total Assets$3.32B

Price / Earnings (P/E)29.8

Price / Sales (P/S)1.5

Analyst Forecast

Company Info

CountryAU

ExchangeOther OTC

CurrencyUSD

ISINUS03634M2089

Price Chart

ANSLY

Ansell Limited ↗ · Other OTC

Healthcare • Medical - Instruments & Supplies

71.79 52WK RANGE 96.27

People Also View

HOYA Corporation

Becton, Dickinson and Company

AptarGroup, Inc.

Sysmex Corporation

ICU Medical, Inc.

Haemonetics Corporation

LeMaitre Vascular, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message